Remove Case Study Remove Digital Health Remove Leadership Remove Mental health
article thumbnail

Personal Health LLM's to emerge in HealthTech 2024?

Lloyd Price

Overall, personal health LLMs have the potential to revolutionize healthcare by providing accessible, informative, and personalized support to users. Growth and M&A for Healthcare Technology companies Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!

article thumbnail

Artificial Emotional Intelligence: What exactly is it? What is the potential of AEI in Healthcare?

Lloyd Price

Mental health: AEI systems can be used to develop new treatments for mental health conditions by providing personalized feedback and support. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Co-Pilot in HealthTech: Revolutionising Healthcare with Human-AI Collaboration

Lloyd Price

Personalisation and Patient Engagement: AI-powered chatbots for mental health support: These chatbots provide emotional support, offer resources, and connect patients with mental health professionals when needed. beds, equipment) efficiently.

article thumbnail

Key Takeaways from Arab Health 2024: Integrated Healthcare Systems, Strengthening Healthcare Infrastructure, Sustainable Healthcare Practices

Lloyd Price

Mental Health and Wellbeing: Increased awareness and stigma reduction around mental healthwere addressed, with sessions on mental health services and support systems. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

What's next for Digital Therapeutics after it all went PEAR shaped?

Lloyd Price

Pear's decline followed in Proteus Digital Health's footsteps after the company filed for bankruptcy in June 2020 having raised over $500 million in funding, a massive $1.5 Billion valuation and loss of a development deal with Otsuka Pharmaceuticals.